LILRB1
(Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1))
Origine
Humain, Souris, Rat
Source
Synthetic
Application
Blocking Peptide (BP)
Attributs du produit
The peptide is used to block Anti-CD85j Antibody reactivity.
Indications d'application
Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
Restrictions
For Research Use only
Format
Lyophilized
Stock
-20 °C
Stockage commentaire
Shipped at 4°C. Store at -20°C for one year.
Date de péremption
12 months
Antigène
LILRB1
(Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1))